Form 4: Thermo Fisher Scientific CFO Stephen Williamson Executes Stock Transactions and Transfers Shares to Trust

Stephen Williamson, CFO of Thermo Fisher Scientific, executed stock transactions including option exercises and share transfers to a Spousal Lifetime Access Trust (SLAT).

Summary

• Stephen Williamson, the Senior VP and CFO of Thermo Fisher Scientific, engaged in multiple transactions involving the company's common stock.
• On May 13, 2024, Williamson exercised stock options to acquire 21,925 shares at a price of $210.68 per share and sold the same amount of shares at $591.27 per share.
• On May 14, 2024, he disposed of 3,297 shares and transferred 12,674 shares into a Spousal Lifetime Access Trust (SLAT) for the benefit of his spouse and/or children.
• Following these transactions, Williamson directly owns 20,510.987 shares and indirectly owns 12,674 shares through the SLAT and 8,844 shares through a GRAT.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing stock transactions by a company executive; it doesn't inherently convey positive or negative sentiment.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to monitor executive compensation and potential alignment with shareholder interests.

Comparison to Industry Standards

• Executive stock transactions are common in publicly traded companies like Thermo Fisher Scientific.
• Companies such as Danaher, Agilent, and PerkinElmer also see regular Form 4 filings from their executives.
• The use of Rule 10b5-1 trading plans is a standard practice to avoid accusations of insider trading, similar to what executives at comparable companies employ.

Related Party Transactions

• The transfer of shares to a Spousal Lifetime Access Trust (SLAT) is a related-party transaction.

Stakeholder Impact

• The transactions may provide insights to shareholders regarding executive compensation and alignment of interests.

Key Dates